MarketCap
Facebook
X
TelegramAnnual report 2025
added 04-01-2026
Aspira Women's Health DPO Ratio 2011-2026 | AWH
Annual DPO Ratio Aspira Women's Health
| 2025 | 2024 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 189 | - | 112 | 129 | 123 | 126 | 110 | 93.3 | 119 | 156 | 333 | 1.16 K | 1.46 K | 3.77 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.77 K | 93.3 | 606 |
Quarterly DPO Ratio Aspira Women's Health
| 2025-Q3 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 161 | 230 | - | 227 | 163 | 141 | - | 123 | 94 | 70.6 | - | 163 | 111 | 137 | - | 129 | 125 | 137 | - | 125 | 170 | 112 | - | 111 | 116 | 139 | - | 111 | 107 | 96.3 | - | 87.3 | 98 | 102 | - | 98.4 | 137 | 162 | - | 119 | 157 | - | - | 169 | 1.16 K | - | - | 1.97 K | 1.45 K | 1.31 K | - | 1.45 K | 1.71 K | 2.23 K | - | 4.67 K | 3.28 K | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 4.67 K | 70.6 | 573 |
DPO Ratio of other stocks in the Diagnostics research industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
120 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Co-Diagnostics
CODX
|
4.24 K | $ 1.48 | -9.51 % | $ 1.97 M |  USA |
 |
Castle Biosciences
CSTL
|
65.8 | $ 18.95 | 0.4 % | $ 549 M | USA |
 |
Fulgent Genetics
FLGT
|
34.9 | $ 15.85 | -2.1 % | $ 479 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
125 | $ 18.56 | - | $ 196 M |  China |
 |
Agilent Technologies
A
|
50.1 | $ 112.0 | -1.1 % | $ 34 B | USA |
|
Akumin
AKU
|
21.3 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
125 | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
56.3 | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
45.8 | - | - | $ 562 M |  Britain |
 |
Interpace Biosciences
IDXG
|
33 | $ 1.8 | -5.26 % | $ 7.96 M | USA |
 |
CareDx, Inc
CDNA
|
44.2 | $ 20.15 | -1.66 % | $ 1.07 B | USA |
 |
Chembio Diagnostics
CEMI
|
52.5 | - | 0.22 % | $ 16.8 M | USA |
 |
Lantheus Holdings
LNTH
|
23.6 | $ 95.11 | -1.61 % | $ 6.42 B | USA |
 |
Medpace Holdings
MEDP
|
13.3 | $ 417.38 | -0.43 % | $ 12 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
112 | - | -20.0 % | $ 1.06 M | USA |
 |
Mettler-Toledo International
MTD
|
53.4 | $ 1 036.33 | -0.53 % | $ 21.4 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
45.9 | $ 3.63 | 0.14 % | $ 336 M | USA |
 |
Global Cord Blood Corporation
CO
|
17.7 | - | - | $ 399 M | China |
 |
NeoGenomics
NEO
|
19.7 | $ 8.31 | -0.6 % | $ 1.06 B | USA |
 |
Fluidigm Corporation
FLDM
|
61.4 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
780 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
43.5 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
47.4 | - | -11.32 % | $ 2.94 M | USA |
 |
Charles River Laboratories International
CRL
|
24.5 | $ 158.4 | -0.56 % | $ 7.85 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
8.98 | - | - | $ 10.7 B | USA |
 |
National Research Corporation
NRC
|
10.1 | $ 18.87 | -0.3 % | $ 422 M | USA |
 |
Natera
NTRA
|
17.9 | $ 191.02 | -2.99 % | $ 18.8 B | USA |
 |
Enzo Biochem
ENZ
|
52.3 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
49.2 | - | - | $ 19.8 B | USA |
 |
Guardant Health
GH
|
48.6 | $ 96.33 | -2.36 % | $ 12.1 B | USA |
 |
Senseonics Holdings
SENS
|
68 | $ 5.71 | -1.89 % | $ 238 M | USA |
 |
Personalis
PSNL
|
65.7 | $ 6.55 | -2.38 % | $ 585 M | USA |
 |
Heska Corporation
HSKA
|
39.7 | - | - | $ 1.31 B | USA |
 |
ICON Public Limited Company
ICLR
|
6.52 | $ 115.8 | -1.11 % | $ 9.55 B |  Irlanda |
 |
Illumina
ILMN
|
56.3 | $ 139.62 | -2.53 % | $ 22.2 B | USA |
 |
Soleno Therapeutics
SLNO
|
1.44 K | $ 52.99 | -0.01 % | $ 2.69 B | USA |
 |
QIAGEN N.V.
QGEN
|
50 | - | - | $ 10.6 B |  Niderland |
 |
Trinity Biotech plc
TRIB
|
163 | $ 0.58 | -0.63 % | $ 208 M | Irlanda |
 |
Biomerica
BMRA
|
32.4 | $ 2.42 | 0.41 % | $ 5.56 M | USA |
 |
Twist Bioscience Corporation
TWST
|
12.5 | $ 50.69 | -4.27 % | $ 3.03 B | USA |
 |
Thermo Fisher Scientific
TMO
|
49.3 | $ 439.8 | -1.86 % | $ 166 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
31.5 | $ 253.87 | -0.09 % | $ 21.1 B | USA |
 |
Motus GI Holdings
MOTS
|
1.72 | - | -34.28 % | $ 263 K |  Israel |
 |
Waters Corporation
WAT
|
102 | $ 329.45 | -1.15 % | $ 19.6 B | USA |
 |
Neogen Corporation
NEOG
|
62.7 | $ 8.39 | -0.47 % | $ 1.82 B | USA |